More Than 500 Pharmas Suspended For Failure To Meet GMP Standards
This article was originally published in PharmAsia News
More than 500 non-qualified manufacturers of sterile drugs have been suspended since Jan. 1, including those that make blood products, vaccines and injections for failing to meet the standards of new good manufacturing practices by the end of last year.
You may also be interested in...
The German pricing and reimbursement system has been successful in recognizing the value and uniqueness of orphan drugs.
Erectile problems prevent a quarter of Brits from being intimate with a partner. Viatris' Upjohn - which markets Viagra Connect in the UK - is working with the Men’s Health Forum, sexual health charity Brook and dating expert Sarah Louise Ryan raise awareness of the problem and get men talking about the issue with their partners and with healthcare professionals.
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.